Igor Matushansky is Chief Medical Officer at HOOKIPA Pharma Inc. (HOOK). They have made 5 open-market trades across 1 company since 2019, most recently 2022-02-01.
CIK 0001768208
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HOOK | 100,240 | $87K |
Shares reported on the most recent Form 4, priced at the 2022-02-01 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HOOK | SELL | 2021-12-21 | 2022-01-12 | $2.49 | $37K | -23.9% | -35.0% | -10.2% |
| HOOK | SELL | 2020-12-16 | 2020-12-18 | $11.74 | $661K | -5.7% | +2.2% | +13.0% |
| HOOK | SELL | 2020-01-29 | 2020-01-31 | $12.73 | $70K | -1.0% | -2.7% | -27.1% |
| HOOK | SELL | 2019-12-19 | 2019-12-23 | $9.93 | $207K | -1.5% | -2.9% | -39.5% |
| HOOK | SELL | 2019-12-17 | 2019-12-19 | $7.87 | $181K | +22.7% | +23.2% | -18.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.